LCI snaps up Pfizer’s manufacturing facility

MG News | September 09, 2024 at 09:24 AM GMT+05:00

0:00

September 09, 2024 (MLN): Marking a significant expansion in LCI's pharmaceutical footprint, Lucky Core Industries Limited (PSX: LCI) has acquired Pfizer Pakistan Limited's manufacturing facility under the Asset Purchase Agreements entered into between the parties.

Along with this, the company has also acquired the products and product registrations consisting of Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D and Mycitracin.

In addition to this trademarks associated with the said pharmaceutical products either through an outright assignment of trademarks or a perpetual license to use the relevant trademarks from relevant Pfizer group entities have also been acquired.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	163,018.66 138.30M	0.05% 81.72
ALLSHR	98,973.80 403.59M	0.17% 164.66
KSE30	49,460.79 51.40M	0.03% 14.97
KMI30	233,011.03 39.62M	0.13% 295.18
KMIALLSHR	64,476.20 200.81M	0.14% 88.53
BKTi	44,076.19 19.45M	0.29% 129.30
OGTi	32,306.98 7.87M	0.17% 56.15

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	84,190.00	88,150.00 81,485.00	-2250.00 -2.60%
BRENT CRUDE	62.54	63.02 62.20	-0.84 -1.33%
RICHARDS BAY COAL MONTHLY	85.00	0.00 0.00	0.25 0.30%
ROTTERDAM COAL MONTHLY	96.25	0.00 0.00	0.15 0.16%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	58.08	58.80 57.75	-0.92 -1.56%
SUGAR #11 WORLD	14.60	14.74 14.59	-0.06 -0.41%